search
Back to results

The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities

Primary Purpose

Venous Insufficiency

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
embolotherapy of incompetent gonadal and iliac veins
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Venous Insufficiency

Eligibility Criteria

18 Years - 50 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • premenopausal women ovarian point tenderness post coital pain atypical lower limb varices

Exclusion Criteria:

  • endometriosis diverticulitis fasciitis psychosexual dysfunction

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Study group

    Arm Description

    perimenopausal women

    Outcomes

    Primary Outcome Measures

    The difference in pain score before and after therapy
    validated analogue scoring of pain From 0 to 10 according to symptoms improvement

    Secondary Outcome Measures

    Full Information

    First Posted
    August 27, 2018
    Last Updated
    August 27, 2018
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03652025
    Brief Title
    The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities
    Official Title
    The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2018
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 15, 2018 (Anticipated)
    Primary Completion Date
    April 15, 2019 (Anticipated)
    Study Completion Date
    June 15, 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    pelvic congestion is the most recognized consequence of pelvi-perineal venous insufficiency . chronic pelvic pain prevalence is about 26.6 %in egypt. this research is going to evaluate the effectiveness of foam sclerotherapy and to conclude diagnostic and therapeutic algorithm for this problem.
    Detailed Description
    this study includes clinical and imaging and interventional aspects. detailed history and comprehensive examination of the patient. duplex ultrasonography to detect pelvic varices and presence of reflux. renal and left iliac venogram is usually the first step in the evaluation of compressive syndrome. then cannulate the gonadal and internal iliac veins selectively. contrast medium injected , the incompetent gonadal veins are generally dilated and the contrast pools in the pelvis after injection. embolization by injecting afoam sclerosant as distally as possible to occlude the pelvic venous plexus using occlusion balloon proximal. follow up assessment by VAS score and duplex imaging.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Venous Insufficiency

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    premenopausal women with dull aching pain with ovarian point tenderness and post coital pain.
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Study group
    Arm Type
    Experimental
    Arm Description
    perimenopausal women
    Intervention Type
    Procedure
    Intervention Name(s)
    embolotherapy of incompetent gonadal and iliac veins
    Intervention Description
    minimally invasive
    Primary Outcome Measure Information:
    Title
    The difference in pain score before and after therapy
    Description
    validated analogue scoring of pain From 0 to 10 according to symptoms improvement
    Time Frame
    one year

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    50 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: premenopausal women ovarian point tenderness post coital pain atypical lower limb varices Exclusion Criteria: endometriosis diverticulitis fasciitis psychosexual dysfunction

    12. IPD Sharing Statement

    Learn more about this trial

    The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities

    We'll reach out to this number within 24 hrs